Abstract
Some patients with autoimmune disease develop antibodies directed against intracellular structures. Despite more than 50 years of research, the etiology of autoantibody formation in these patients remains unknown. Autoantibody formation may precede the development of clinical disease manifestations by years if not decades (Arbuckle et al. 2003; Prince et al. 2004). It therefore seems likely that autoantibodies are involved in the earliest events that occur in an autoimmune disease. Autoantibodies may provide the only clue to the environmental exposure, such as a viral infection, that initiates autoimmune diseases in susceptible individuals.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526–1533
Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8:1006–1016
Bhanji RA, Eystathioy T, Chan EK, Bloch DB, Fritzler MJ (2007) Clinical and serological features of patients with autoantibodies to GW/P bodies. Clin Immunol 125:247–256
Bloch DB, Rabkina D, Quertermous T, Bloch KD (1994) The immunoreactive region in a novel autoantigen contains a nuclear localization sequence. Clin Immunol Immunopathol 72:380–389
Bloch DB, de la Monte SM, Guigaouri P, Filippov A, Bloch KD (1996) Identification and characterization of a leukocyte-specific component of the nuclear body. J Biol Chem 271:29198–29204
Bloch DB, Nakajima A, Gulick T, Chiche JD, Orth D, de La Monte SM, Bloch KD (2000) Sp110 localizes to the PML-Sp100 nuclear body and may function as a nuclear hormone receptor transcriptional coactivator. Mol Cell Biol 20:6138–6146
Bloch DB, Yu JH, Yang WH, Graeme-Cook F, Lindor KD, Viswanathan A, Bloch KD, Nakajima A (2005) The cytoplasmic dot staining pattern is detected in a subgroup of patients with primary biliary cirrhosis. J Rheumatol 32:477–483
Bloch DB, Gulick T, Bloch KD, Yang WH (2006) Processing body autoantibodies reconsidered. RNA 12:707–709
Bussow K, Nordhoff E, Lubbert C, Lehrach H, Walter G (2000) A human cDNA library for high-throughput protein expression screening. Genomics 65:1–8
Evdokimova V, Ruzanov P, Imataka H, Raught B, Svitkin Y, Ovchinnikov LP, Sonenberg N (2001) The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J 20:5491–5502
Eystathioy T, Chan EK, Tenenbaum SA, Keene JD, Griffith K, Fritzler MJ (2002) A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles. Mol Biol Cell 13:1338–1351
Eystathioy T, Jakymiw A, Chan EK, Seraphin B, Cougot N, Fritzler MJ (2003) The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies. RNA 9:1171–1173
Fenger-Grøn M, Fillman C, Norrild B, Lykke-Andersen J (2005) Multiple processing body factors and the ARE binding protein TTP activate mRNA decapping. Mol Cell 20:905–915
Garcia-Lozano JR, Gonzalez-Escribano MF, Wichmann I, Nunez-Roldan A (1997) Cytoplasmic detection of a novel protein containing a nuclear localization sequence by human autoantibodies. Clin Exp Immunol 107:501–506
Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353:1261–1273
Kutay U, Guttinger S (2005) Leucine-rich nuclear-export signals: born to be weak. Trends Cell Biol 15:121–124
Lieb B, Carl M, Hock R, Gebauer D, Scheer U (1998) Identification of a novel mRNA-associated protein in oocytes of Pleurodeles waltl and Xenopus laevis. Exp Cell Res 245:272–281
Moser JJ, Chan EK, Fritzler MJ (2009) Optimization of immunoprecipitation-western blot analysis in detecting GW182-associated components of GW/P bodies. Nat Protoc 4:674–685
Neer EJ, Schmidt CJ, Nambudripad R, Smith TF (1994) The ancient regulatory-protein family of WD-repeat proteins. Nature 371:297–300
Prince MI, Chetwynd A, Craig WL, Metcalf JV, James OF (2004) Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53:865–870
Renault L, Nassar N, Vetter I, Becker J, Klebe C, Roth M, Wittinghofer A (1998) The 1.7 A crystal structure of the regulator of chromosome condensation (RCC1) reveals a seven-bladed propeller. Nature 392:97–101
Rihs H-P, Peters R (1989) Nuclear transport kinetics depend on phosphorylation-site-containing sequences flanking the karyophilic signal of the Simian virus 40T-antigen. EMBO J 8:1479–1484
Satoh M, Chan EK, Sobel ES, Kimpel DL, Yamasaki Y, Narain S, Mansoor R, Reeves WH (2007) Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 3:721–738
Sternsdorf T, Guldner HH, Szostecki C, Grotzinger T, Will H (1995) Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 42:257–268
Stinton LM, Eystathioy T, Selak S, Chan EK, Fritzler MJ (2004) Autoantibodies to protein transport and messenger RNA processing pathways: endosomes, lysosomes, Golgi complex, proteasomes, assemblyosomes, exosomes, and GW bodies. Clin Immunol 110:30–44
Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151
Tan EM (1993) Molecular biology of nuclear autoantigens. Adv Nephrol Necker Hosp 22:213–236
Yang WH, Bloch DB (2007) Probing the mRNA processing body using protein macroarrays and “autoantigenomics”. RNA 13:704–712
Yang WH, Yu JH, Nakajima A, Neuberg D, Lindor K, Bloch DB (2004) Do antinuclear antibodies in primary biliary cirrhosis patients identify increased risk for liver failure? Clin Gastroenterol Hepatol 2:1116–1122
Yang WH, Yu JH, Gulick T, Bloch KD, Bloch DB (2006) RNA-associated protein 55 (RAP55) localizes to mRNA processing bodies and stress granules. RNA 12:547–554
Yu JH, Yang WH, Gulick T, Bloch KD, Bloch DB (2005) Ge-1 is a central component of the mammalian cytoplasmic mRNA processing body. RNA 11:1795–1802
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Bloch, D.B., Nobre, R.A., Yang, WH. (2013). GW/P-Bodies and Autoimmune Disease. In: Chan, E., Fritzler, M. (eds) Ten Years of Progress in GW/P Body Research. Advances in Experimental Medicine and Biology, vol 768. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5107-5_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-5107-5_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-5106-8
Online ISBN: 978-1-4614-5107-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)